| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $864.7M | +122.8% |
| Cost of Revenue | $721.1M | +124.3% |
| R&D Expense | $19.8M | +7.1% |
| SG&A Expense | $56.4M | -10.2% |
| Operating Income | $42.7M | +207.0% |
| Interest Expense | $13.3M | -13.2% |
| Pre-tax Income | $23.5M | +141.2% |
| Income Tax | $1.4M | +398.9% |
| Net Income | $16.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.3M | +150.5% |
| Accounts Receivable | $142.9M | +165.8% |
| Current Assets | $189.9M | +154.7% |
| Total Assets | $262.4M | +70.5% |
| Current Liabilities | $133.0M | +66.8% |
| Long-term Debt | $162.4M | -6.8% |
| Total Liabilities | $308.7M | +24.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $45.9M | +126.7% |
| Capital Expenditures | $254K | +247.9% |
| Investing Cash Flow | -$654K | -795.9% |
| Financing Cash Flow | -$19.2M | -10.3% |
| Free Cash Flow | $45.6M | +126.3% |
| +141.1% |
| EPS (Basic) | $0.31 | +134.8% |
| EPS (Diluted) | $0.31 | +134.8% |
| Stockholders' Equity |
| $2.4M |
| +123.1% |